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Genetic and virulence characterization of colistin-resistant and colistin-sensitive A. 
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Abstract 
Treatment of infections caused by A. baumannii is becoming a challenge due to the 
ability to develop multidrug-resistance, virulence, and high mortality. We described the 
colistin resistance and virulence genes present in six A. baumannii clinical isolates using 
WGS, expression by qPCR, and, virulence in the Galleria mellonella model. The colistin-
resistant isolates were assigned as ST233 and the colistin-susceptible isolates as ST236 and 
ST407. The colistin-resistant isolates contained mutations within PmrA/PmrB and the 
pmrA showed up-regulation in all of them. Only one colistin-resistant isolate indicating 
virulence in G. mellonella. This particular isolate belonged to a different clone, and it was 
the only isolate that present non-synonymous mutations in pmrB. Colistin-resistance in A. 
baumannii isolates seems to be caused by up-regulation of pmrA gene. Only one isolate 
appeared to be virulent in the G. mellonella model. This finding indicating low virulence in 
isolates belonging to emerging clones circulating in our hospital. 
Keywords: Acinetobacter baumannii, Galleria mellonella, whole-sequencing, colistin-
resistant, resistance, virulence. 
 
Colistin is the last resort for treatment of infections caused by carbapenem-resistant 
Acinetobacter baumannii (Biswas et al, 2012 Dias et al, 2016). To date, the expression of 
several A. baumannii virulence genes has been linked to the persistence and survival of A. 
baumannii within the host (Zarrilli, 2016). Moreover, the role of colistin resistance on 
Acinetobacter virulence remains controversial (Wand et al, 2015). Galleria is a non-
vertebrate model that has been used as an alternative to traditional models of infection 
(López-Rojas et al, 2011). Therefore, we evaluated the virulence of A. baumannii isolates 
comparing colistin-resistant and -susceptible isolates in the Galleria mellonella model. In 
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addition, we identified resistance and virulence genes present in MDR A. baumannii 
isolates, in order to observe the relationship between virulence and resistance.  
Six A. baumannii clinical isolates were selected from the Laboratory of Bacteriology 
bacterial collection of the Department of Infectious Diseases, University of São Paulo, 
Brazil. They were chosen based on colistin susceptibility according to Clinical and 
Laboratory Standards Institute (CLSI) (CLSI, 2013), carbapenems resistance mechanism, 
year of identification, sequence type (ST), and Pulsed-field gel electrophoresis (PFGE) 
from a previous study (Supplemental Material – table S1) (Leite et al, 2016). The whole 
genome sequencing (WGS) was performed by Ion Torrent Personal Genome Technology 
Machine
TM 
(PGM) system using a 318 chip (Life Technologies, Foster City, CA). SNPs 
were identified using Samtools (Li et al, 2009) with A. baumannii str. AYE (CU459141.1). 
ResFinder 2.0, BLAST and MAFFT (Katoh and Standley, 2013) were used to identify 
antibiotic resistance gene. Colistin-resistant isolates were compared to the ColR28 isolated 
due to different behavior in the Galleria model. Gene expression studies were carried out 
on a StepOne® Real Time (Applied Biosystems, USA), using Quantifast® SYBR®Green 
RT-PCR (Qiagen, CA, USA) as directed by the manufacturer. Bacterial RNA was purified 
using the RNeasy mini kit (Qiagen, West Sussex, United Kingdom). The 16S rRNA gene 
was used as a reference endogenous gene for gene expression normalization and A. 
baumannii ATCC 19606 as reference isolates. Colistin-resistant isolates were cultured with 
and without colistin (4 mg/L). Negative controls without reverse transcriptase were 
included to detect DNA contamination. The level of expression was considering up-
regulation >0.5, according to relative quantification using 16S for 2
-ΔΔCt
 (Livak and 
Schmittgen, 2001; Pfaffl, 2004). The G. mellonella larvae assay was performed to 
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evaluated A. baumannii virulence as described by (Kavanagh and Fallon, 2010). All 
experiments were performed in triplicate. 
The genetic and virulence characteristics of six A. baumannii isolates defined as MDR 
(Leite et al, 2016) and assigned as ST236, ST407, and ST233 are shown in table 1.  
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Table 1. Virulence genes and protein function determined by WGS among the six multidrug-resistant A. baumannii isolates. 
Isolates Year Clusters ST/CC 
Biofilm 
maturation 
Acinetobactin biosynthesis and 
transport 
Iron acquisition system 
Phospholipase 
D 
Outer membrane 
porin 
Adherence  
Immune system 
evasion 
ColS3 2003 C 236/103 Bap bauDCEBAbasCD, pbpG, tonB plc, plcD  ompA, omp33-36 
lpsB, lpxA, lpxB, lpxC, 
lpxD, lpxL, lpxM 
ColS6 2002 C 236/103 Bap bauDCEBAbasCD, pbpG, tonB plc, plcD  ompA, omp33-36 
lpsB, lpxA, lpxB, lpxC, 
lpxD, lpxL, lpxM 
ColS18 2004 D 407/st NI bauDCEBAbasCD, pbpG, tonB plc, plcD  ompA, omp33-36 
lpsB, lpxA, lpxB, lpxC, 
lpxD, lpxL, lpxM 
ColR23 2012 A1 233/113 Bap bauDCEBAbasCD, pbpG, tonB plc, plcD  ompA, omp33-36 
lpsB, lpxA, lpxB, lpxC, 
lpxD, lpxL, lpxM 
ColR25 2011 A 233/113 Bap bauDCEBAbasCD, pbpG, tonB plc, plcD  ompA, omp33-36 
lpsB, lpxA, lpxB, lpxC, 
lpxD, lpxL, lpxM 
ColR28 2011 B 233/113 NI bauDCEBAbasCD, pbpG, tonB plc, plcD  ompA, omp33-36 
lpsB, lpxA, lpxB, lpxC, 
lpxD, lpxL, lpxM 
Abbreviations: MIC: Minimum Inhibitory Concentration; ST - Sequence type; CC - Clonal complex; st - singleton
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Biofilm has been described as a virulence factor in A. baumannii and several authors 
suggested that the development of biofilm structure and intercellular adhesion were closely 
associated with Bap family proteins (Loehfelm et al, 2008; Goh et al, 2013). In our study, 
the quorum-sensing gene abaI was not found in ColR isolates and ColR28 isolate virulent 
in the G. mellonella model and ColS18 lost bap gene. Virulence regulator gene GacS 
showed one amino acid substitution (E510D) among ColR isolates and in ColS isolates the 
substitution was not observed. In A. baumannii, the pili involved in biofilm formation is 
produced by the csuA/BABCDE usher-chaperone assembly system, which is regulated by 
the two-component system bfmRS (Tomaras et al, 2008). In the present study, the regulator 
BfmS showed a single mutation (N453S) in six isolates, however, the substitution was not 
observed in the BfmR. 
We observed that the expression of pmrA in colistin-resistant isolates occurred 
irrespective of the presence of colistin (figure 1A), indicating that the elevated expression 
of the gene appears to be constitutive and not induced by the presence of colistin (Park et 
al, 2011). The ColR23 and ColR25 resistant isolates showed mutations in the PmrA (D82G, 
S119T) and in the PmrB (G21V, V227A). Whereas the ColR28 resistant isolate showed 
only a single mutation in the PmrB (P170L). It is consistent with increased pmrA 
expression described by Adams et al (2009) and Arroyo et al (2011). In addition, up-
regulation of pmrB was identified in ColR23 and up-regulation of pmrC in ColR23 and 
ColR28 (figure 1B). Both ColS3 and ColS6 showed the same mutations in the PmrC 
(V51A; V111G; R137P; S149V; Y341L; Q403P). Non-synonymous mutations were not 
observed in the lpxACD. Quantitative-PCR analysis demonstrated no overexpression with 
the exception of ColS3 lpxA (0.61), ColR23 lpxA (0.74) and ColR23 lpxC (0.73).  
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Figure 1. Expression of pmrCAB operon for all A. baumannii isolates. 
A- Expression observed in the absent of colistin for all isolates. B- 
Expression observed in the presence of colistin [4mg/L] for colistin-
resistant isolates. ATCC 19606 – standard isolate, basal expression 0.5 
according to relative quantification using 16S for 2
-ΔΔCt
. 
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Low rates of mortality were found in the G. mellonella model in our casuistic 
(Supplemental Material – Figure 2). Only ColR28 demonstrated limited virulence, killing 
50% larvae 72 hours post-infection. Although the three colistin-resistant isolates were 
assigned as ST233, only the ColR28 showed a single non-synonymous mutation in pmrB 
and belonged to a different clone. Wand et al, 2015 observed that isolates carrying pmrB 
gene mutation retained virulence levels in the Galleria model. To investigate the genetic 
changes behind this ColR28, it was compared to the other two ColR isolates (ColR23 and 
ColR25). The ColR23 and ColR25 isolates showed synonymous mutations in csuD and 
pgaC genes comparing to ColR28. A recent study showed that the potential to adapt to 
colistin and virulence differs between mutants of clonally-distinct isolates and that 
mutations in pmrB do not always lead to loss of virulence, however, mutations in lpxACD 
show loss of virulence and increased susceptibility to several antibiotics (Wand et al, 2015). 
Non-synonymous mutations were not observed for the six isolates in the lpxACD. 
An important limitation of our casuistic is that apparently, the colistin-susceptible 
isolates studied were not the ideal isolates to conduct the in vivo model. Thus, further 
studies need to be conducted to confirm our findings.  
The colistin-resistance in our A. baumannii isolates assigned as ST233 seems to be 
caused by up-regulation of pmrA gene. The expression of the gene was probably 
constitutive and not induced by the presence of colistin. Although A. baumannii isolates 
contained several virulence genes, only one colistin-resistant isolate appeared to be virulent 
in the G. mellonella model. This finding indicating low virulence in isolates belonging to 
emerging clones circulating in our hospital. 
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Table 1. Virulence genes and protein function determined by WGS among the six 
multidrug-resistant A. baumannii isolates. 
Isolates Year Clusters ST/CC 
Biofilm 
maturation 
Acinetobactin biosynthesis 
and transport 
Iron acquisition system 
Phospholipase 
D 
Outer 
membrane 
porin 
Adherence  
Immune system 
evasion 
ColS3 2003 C 236/103 Bap 
bauDCEBAbasCD, pbpG, 
tonB plc, plcD  
ompA, omp33-
36 
lpsB, lpxA, lpxB, 
lpxC, lpxD, lpxL, 
lpxM 
ColS6 2002 C 236/103 Bap 
bauDCEBAbasCD, pbpG, 
tonB plc, plcD  
ompA, omp33-
36 
lpsB, lpxA, lpxB, 
lpxC, lpxD, lpxL, 
lpxM 
ColS18 2004 D 407/st NI 
bauDCEBAbasCD, pbpG, 
tonB plc, plcD  
ompA, omp33-
36 
lpsB, lpxA, lpxB, 
lpxC, lpxD, lpxL, 
lpxM 
ColR23 2012 A1 233/113 Bap 
bauDCEBAbasCD, pbpG, 
tonB plc, plcD  
ompA, omp33-
36 
lpsB, lpxA, lpxB, 
lpxC, lpxD, lpxL, 
lpxM 
ColR25 2011 A 233/113 Bap 
bauDCEBAbasCD, pbpG, 
tonB plc, plcD  
ompA, omp33-
36 
lpsB, lpxA, lpxB, 
lpxC, lpxD, lpxL, 
lpxM 
ColR28 2011 B 233/113 NI 
bauDCEBAbasCD, pbpG, 
tonB plc, plcD  
ompA, omp33-
36 
lpsB, lpxA, lpxB, 
lpxC, lpxD, lpxL, 
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lpxM 
Abbreviations: MIC: Minimum Inhibitory Concentration; ST - Sequence type; CC - 
Clonal complex; st - singleton 
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